Every brand has a rhythm to its earnings calls. There's the opening statement about "continued momentum" and "global growth." There's the pipeline number, which always goes up because letters of intent are cheap and make great slides. There's the adjusted EBITDA figure, which strips out whatever they'd rather you not think about. And then there's the Q&A, which is where the real story lives... if the analysts ask the right questions. Wyndham's April 30 call is going to follow that rhythm to the letter, and I'd bet my filing cabinet on it.

Here's what we know going in. Full-year 2025 net income dropped 33%, from $289 million to $193 million, largely because a major European franchisee filed for insolvency and created $160 million in non-cash charges. Wyndham will tell you to look at adjusted net income instead, which rose 2% to $353 million, and adjusted EBITDA, which climbed 3% to $718 million. Fine. But the U.S. RevPAR story is the one that matters to the people actually writing franchise fee checks. Q4 2025 saw an 8% RevPAR decline domestically. Eight percent. For an economy and midscale portfolio where margins are already razor-thin, that's not a blip... that's the difference between an owner making money and an owner subsidizing the brand's growth story. The 2026 outlook projects 4-4.5% net room growth and fee-related revenues between $1.46 billion and $1.49 billion. The pipeline hit a record 259,000 rooms. All of which sounds terrific if you're the one collecting fees. If you're the one paying them while your RevPAR contracts, the math feels very different.

And this is what I keep coming back to... the structural tension between Wyndham's corporate narrative and the franchisee experience. The company returned $393 million to shareholders in 2025 through buybacks and dividends. The board just bumped the quarterly dividend 5%. The stock is down nearly 11% over the past year, sure, but the message to Wall Street is clear: we're generating cash and we're returning it. Meanwhile, at property level, owners are absorbing brand-mandated technology costs (Wyndham Connect PLUS, whatever that ultimately requires), marketing assessments for a new portfolio-wide campaign, loyalty program costs, and PIP requirements... all while RevPAR declines eat into the revenue those fees are calculated against. I sat in a franchise review once where the owner pulled out a calculator mid-presentation and just started doing the math on total brand cost as a percentage of his actual revenue. The room got very quiet. That's the moment brands don't prepare for, and it's the moment that's coming for a lot of Wyndham owners if U.S. RevPAR doesn't recover.

The new CFO, Amit Sripathi, is stepping into this call less than two months into the job. He'll get a honeymoon. But the questions he needs to answer aren't about adjusted EBITDA growth or ancillary revenue increases (which rose 15% in 2025... lovely for corporate, but ancillary revenue doesn't flow to the franchisee). The questions are: What is the actual loyalty contribution rate at property level versus what was projected in the FDD? What is the total cost of brand affiliation as a percentage of gross revenue for the median U.S. franchisee? And when RevPAR declines 8% but franchise fees don't decline at all, who exactly is absorbing that pain? (Spoiler: it's not the publicly traded company buying back shares.) The "OwnerFirst" branding is clever. I'd like to see it in the numbers, not just the tagline.

Here's the thing about Wyndham that makes them fascinating and frustrating in equal measure. They are genuinely good at what they do on the development side. Record pipeline. Global expansion into underserved markets. Branded residences in the mid-price segment. Trademark Collection crossing 100 U.S. hotels. That's real execution. But development success and franchisee success are not the same metric, and the gap between them is where trust erodes. You can grow the system by 4% annually while your existing owners are watching their returns compress, and if you do that long enough, the owners stop renewing. I've seen this brand movie before with other companies. The sequel is never as good as the original.

Pebblebrook's Q1 2026 same-property hotel EBITDA guidance sits at $70M-$74M. That's the number. Not the RevPAR growth range (7.5%-9.0%), which is what management wants you to focus on. The EBITDA range is what tells you whether revenue is actually flowing to the bottom line or getting absorbed by labor and operating costs on the way down.

Full-year 2025: $1.48 billion in revenue, negative $65.8 million net income. The 2026 outlook brackets somewhere between losing another $10.4 million and earning $3.6 million. That's a $14 million swing and the midpoint is roughly breakeven. For a 44-property, 11,000-room portfolio concentrated in urban and resort markets, breakeven after a year and a half of "recovery" tells you something about the cost structure. Adjusted FFO per diluted share was $1.58 for 2025. Stock trades around $12. You're paying roughly 7.6x trailing FFO for a portfolio that hasn't produced positive net income yet. That's either a deep value play or a trap, and the Q1 call is where we start to find out which.

The balance sheet moves are worth decomposing. $450 million unsecured term loan closed in February, maturing 2031. $650 million revolver extended to October 2029. Two hotel sales in Q4 for $116.3 million, $100 million of which went straight to debt reduction. Management is clearly de-risking the capital structure, which is smart... but selling assets to pay down debt while your stock trades at roughly 50% of NAV (Palogic's estimate, and they're not wrong) means you're liquidating at a discount to fund solvency. An owner I worked with once described this exact dynamic: "I'm selling dollars for fifty cents to keep the lights on." He wasn't wrong either.

The San Francisco story is the one analysts keep pointing to. Truist called it "potentially one of the best storylines" in lodging REIT coverage for 2026. Fine. But "best storyline" and "best returns" aren't the same thing. Pebblebrook has heavy exposure to SF, and the easy comps from 2024-2025 will flatter year-over-year numbers. The question is whether the absolute RevPAR levels in those urban markets generate enough contribution after brand costs, labor, and deferred maintenance to justify the capital tied up in these assets. RevPAR growth on a depressed base is math, not recovery.

Thirteen analysts cover this stock. Six say sell. Five say hold. One buy. One strong buy. That distribution tells you the consensus view: the portfolio is real, the assets are good, but the path to consistent positive net income is still unclear. If Q1 EBITDA comes in at the low end of the $70M-$74M range, expect the NAV discount conversation to intensify. If it comes in above $74M, management buys another quarter of credibility. Either way, the number to watch isn't RevPAR. It's flow-through.